Cell Therapeutics, Inc. (CTIC) announced the results from its Annual Meeting of Shareholders held on October 20, 2009.
At the meeting, shareholders elected Richard Love, Mary Mundinger, and Jack Singer to serve on the Company's Board of Directors until the 2012 Annual Meeting. Shareholders also approved the proposals to increase the number of shares available for issuance under its 2007 Equity Incentive Plan, increase the number of shares available for issuance under its 2007 Employee Purchase Plan and issue shares of common stock in lieu of future milestone payments related to the Company's drug candidate brostallicin.
Further, shareholders ratified the selection of Stonefield Josephson, Inc. as the Company's independent auditors for the year ending December 31, 2009.
For comments and feedback: editorial@rttnews.com